Foley & Lardner LLP
Methods for enhancing synaptogenesis and neuritogenesis
Disclosed here is a method for enhancing synaptogenesis and/or neuritogenesis, reducing neurodegeneration, and/or reducing accumulation or aggregation of Tau proteins in a subject suffering from cochlear synaptopathy or vestibular synaptopathy or a central nervous system disease or condition, comprising administering to said subject in need thereof an effective amount of 2,4-disulfonyl α-phenyl tertiary butyl nitrone (2,4-DSPBN) or a pharmaceutically acceptable salt thereof. The method may further comprise administrating N-acetylcysteine (NAC) to the subject.
Hough Ear Institute
C A A A A A A A A A A A A
C07K A61K A61K A61P A61P A61K A61K A61K A61K A61K A61K A61K A61P
inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional
Wei Richard D.
Li Kopke